nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—pulmonary artery—thymus cancer	0.0632	0.145	CbGeAlD
Carvedilol—SELE—vein—thymus cancer	0.0388	0.0894	CbGeAlD
Carvedilol—VCAM1—vein—thymus cancer	0.0357	0.0822	CbGeAlD
Carvedilol—Glucose tolerance impaired—Octreotide—thymus cancer	0.0237	0.0539	CcSEcCtD
Carvedilol—Diabetic—Octreotide—thymus cancer	0.0191	0.0435	CcSEcCtD
Carvedilol—Breast feeding—Octreotide—thymus cancer	0.0183	0.0415	CcSEcCtD
Carvedilol—Clotting—Octreotide—thymus cancer	0.0179	0.0406	CcSEcCtD
Carvedilol—Sinus bradycardia—Octreotide—thymus cancer	0.013	0.0296	CcSEcCtD
Carvedilol—NPPB—hematopoietic system—thymus cancer	0.00971	0.0224	CbGeAlD
Carvedilol—Paranoia—Octreotide—thymus cancer	0.00938	0.0213	CcSEcCtD
Carvedilol—Neuralgia—Octreotide—thymus cancer	0.0092	0.0209	CcSEcCtD
Carvedilol—KCNH2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.00874	0.0696	CbGpPWpGaD
Carvedilol—Coagulopathy—Octreotide—thymus cancer	0.00821	0.0186	CcSEcCtD
Carvedilol—VCAM1—neck—thymus cancer	0.00811	0.0187	CbGeAlD
Carvedilol—HIF1A—neck—thymus cancer	0.0078	0.018	CbGeAlD
Carvedilol—GJA1—neck—thymus cancer	0.00757	0.0174	CbGeAlD
Carvedilol—NPPB—cardiac atrium—thymus cancer	0.00737	0.017	CbGeAlD
Carvedilol—Viral infection—Octreotide—thymus cancer	0.00708	0.0161	CcSEcCtD
Carvedilol—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00703	0.016	CcSEcCtD
Carvedilol—VCAM1—Extracellular matrix organization—MUSK—thymus cancer	0.00694	0.0553	CbGpPWpGaD
Carvedilol—NPPB—lymphoid tissue—thymus cancer	0.00684	0.0157	CbGeAlD
Carvedilol—Hearing impaired—Octreotide—thymus cancer	0.00671	0.0152	CcSEcCtD
Carvedilol—NDUFC2—neck—thymus cancer	0.00659	0.0152	CbGeAlD
Carvedilol—SELE—hematopoietic system—thymus cancer	0.00656	0.0151	CbGeAlD
Carvedilol—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00639	0.0145	CcSEcCtD
Carvedilol—Hyperkalaemia—Octreotide—thymus cancer	0.00628	0.0143	CcSEcCtD
Carvedilol—Wheezing—Octreotide—thymus cancer	0.00621	0.0141	CcSEcCtD
Carvedilol—HIF1A—Notch-mediated HES/HEY network—MAML2—thymus cancer	0.00611	0.0487	CbGpPWpGaD
Carvedilol—HIF1A—NOTCH1 Intracellular Domain Regulates Transcription—MAML2—thymus cancer	0.00611	0.0487	CbGpPWpGaD
Carvedilol—VCAM1—hematopoietic system—thymus cancer	0.00603	0.0139	CbGeAlD
Carvedilol—SELE—epithelium—thymus cancer	0.006	0.0138	CbGeAlD
Carvedilol—Cramps of lower extremities—Octreotide—thymus cancer	0.00587	0.0133	CcSEcCtD
Carvedilol—HIF1A—hematopoietic system—thymus cancer	0.00581	0.0134	CbGeAlD
Carvedilol—GJA1—hematopoietic system—thymus cancer	0.00563	0.013	CbGeAlD
Carvedilol—VCAM1—epithelium—thymus cancer	0.00552	0.0127	CbGeAlD
Carvedilol—Sleep disorder—Octreotide—thymus cancer	0.00536	0.0122	CcSEcCtD
Carvedilol—Diabetes mellitus—Octreotide—thymus cancer	0.00533	0.0121	CcSEcCtD
Carvedilol—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00533	0.0121	CcSEcCtD
Carvedilol—HIF1A—epithelium—thymus cancer	0.00531	0.0122	CbGeAlD
Carvedilol—GJA1—epithelium—thymus cancer	0.00515	0.0119	CbGeAlD
Carvedilol—Nasal congestion—Octreotide—thymus cancer	0.00509	0.0116	CcSEcCtD
Carvedilol—Injury—Octreotide—thymus cancer	0.00505	0.0115	CcSEcCtD
Carvedilol—HIF1A—Notch Signaling Pathway—MAML2—thymus cancer	0.00496	0.0395	CbGpPWpGaD
Carvedilol—Amnesia—Octreotide—thymus cancer	0.00494	0.0112	CcSEcCtD
Carvedilol—NDUFC2—hematopoietic system—thymus cancer	0.0049	0.0113	CbGeAlD
Carvedilol—SELE—pituitary gland—thymus cancer	0.00487	0.0112	CbGeAlD
Carvedilol—Anaphylactoid reaction—Octreotide—thymus cancer	0.00479	0.0109	CcSEcCtD
Carvedilol—Arthritis—Octreotide—thymus cancer	0.00477	0.0108	CcSEcCtD
Carvedilol—Hypoglycaemia—Octreotide—thymus cancer	0.00475	0.0108	CcSEcCtD
Carvedilol—HIF1A—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—CDKN2A—thymus cancer	0.00473	0.0377	CbGpPWpGaD
Carvedilol—Pain in extremity—Octreotide—thymus cancer	0.00464	0.0105	CcSEcCtD
Carvedilol—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00464	0.0105	CcSEcCtD
Carvedilol—SELE—lymphoid tissue—thymus cancer	0.00462	0.0106	CbGeAlD
Carvedilol—VCAM1—cardiac atrium—thymus cancer	0.00458	0.0106	CbGeAlD
Carvedilol—Psychotic disorder—Octreotide—thymus cancer	0.00453	0.0103	CcSEcCtD
Carvedilol—KCNH2—Potassium Channels—KCNA4—thymus cancer	0.00449	0.0357	CbGpPWpGaD
Carvedilol—NDUFC2—epithelium—thymus cancer	0.00448	0.0103	CbGeAlD
Carvedilol—VCAM1—pituitary gland—thymus cancer	0.00448	0.0103	CbGeAlD
Carvedilol—HIF1A—cardiac atrium—thymus cancer	0.00441	0.0102	CbGeAlD
Carvedilol—HIF1A—FBXW7 Mutants and NOTCH1 in Cancer—MAML2—thymus cancer	0.0044	0.035	CbGpPWpGaD
Carvedilol—Dehydration—Octreotide—thymus cancer	0.00431	0.0098	CcSEcCtD
Carvedilol—HIF1A—pituitary gland—thymus cancer	0.00431	0.00992	CbGeAlD
Carvedilol—GJA1—cardiac atrium—thymus cancer	0.00428	0.00985	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—thymus cancer	0.00425	0.00978	CbGeAlD
Carvedilol—SELE—thyroid gland—thymus cancer	0.00419	0.00966	CbGeAlD
Carvedilol—GJA1—pituitary gland—thymus cancer	0.00418	0.00962	CbGeAlD
Carvedilol—Cramp muscle—Octreotide—thymus cancer	0.00418	0.00949	CcSEcCtD
Carvedilol—Nasopharyngitis—Octreotide—thymus cancer	0.00415	0.00942	CcSEcCtD
Carvedilol—HIF1A—lymphoid tissue—thymus cancer	0.00409	0.00941	CbGeAlD
Carvedilol—Influenza—Octreotide—thymus cancer	0.00401	0.00911	CcSEcCtD
Carvedilol—GJA1—lymphoid tissue—thymus cancer	0.00397	0.00913	CbGeAlD
Carvedilol—Bronchospasm—Octreotide—thymus cancer	0.00394	0.00896	CcSEcCtD
Carvedilol—Sweating increased—Octreotide—thymus cancer	0.00391	0.00887	CcSEcCtD
Carvedilol—VCAM1—bone marrow—thymus cancer	0.00387	0.00891	CbGeAlD
Carvedilol—VCAM1—thyroid gland—thymus cancer	0.00386	0.00889	CbGeAlD
Carvedilol—Bronchitis—Octreotide—thymus cancer	0.00386	0.00876	CcSEcCtD
Carvedilol—SELE—lung—thymus cancer	0.00381	0.00877	CbGeAlD
Carvedilol—Upper respiratory tract infection—Octreotide—thymus cancer	0.00373	0.00846	CcSEcCtD
Carvedilol—NDUFC2—cardiac atrium—thymus cancer	0.00372	0.00857	CbGeAlD
Carvedilol—HIF1A—bone marrow—thymus cancer	0.00372	0.00857	CbGeAlD
Carvedilol—HIF1A—thyroid gland—thymus cancer	0.00371	0.00855	CbGeAlD
Carvedilol—Pollakiuria—Octreotide—thymus cancer	0.0037	0.00841	CcSEcCtD
Carvedilol—Weight increased—Octreotide—thymus cancer	0.00365	0.00829	CcSEcCtD
Carvedilol—NDUFC2—pituitary gland—thymus cancer	0.00364	0.00837	CbGeAlD
Carvedilol—Weight decreased—Octreotide—thymus cancer	0.00363	0.00824	CcSEcCtD
Carvedilol—Hyperglycaemia—Octreotide—thymus cancer	0.00362	0.00822	CcSEcCtD
Carvedilol—GJA1—bone marrow—thymus cancer	0.00361	0.00831	CbGeAlD
Carvedilol—GJA1—thyroid gland—thymus cancer	0.0036	0.00829	CbGeAlD
Carvedilol—Pneumonia—Octreotide—thymus cancer	0.0036	0.00817	CcSEcCtD
Carvedilol—Depression—Octreotide—thymus cancer	0.00356	0.0081	CcSEcCtD
Carvedilol—VCAM1—lung—thymus cancer	0.0035	0.00807	CbGeAlD
Carvedilol—Urinary tract infection—Octreotide—thymus cancer	0.00347	0.00789	CcSEcCtD
Carvedilol—NDUFC2—lymphoid tissue—thymus cancer	0.00345	0.00795	CbGeAlD
Carvedilol—Haematuria—Octreotide—thymus cancer	0.00341	0.00774	CcSEcCtD
Carvedilol—VEGFA—cardiac atrium—thymus cancer	0.00338	0.00778	CbGeAlD
Carvedilol—HIF1A—lung—thymus cancer	0.00337	0.00777	CbGeAlD
Carvedilol—Sinusitis—Octreotide—thymus cancer	0.00335	0.00762	CcSEcCtD
Carvedilol—VEGFA—pituitary gland—thymus cancer	0.0033	0.0076	CbGeAlD
Carvedilol—GJA1—lung—thymus cancer	0.00327	0.00753	CbGeAlD
Carvedilol—Bradycardia—Octreotide—thymus cancer	0.00327	0.00742	CcSEcCtD
Carvedilol—Rhinitis—Octreotide—thymus cancer	0.00322	0.00731	CcSEcCtD
Carvedilol—Hypoaesthesia—Octreotide—thymus cancer	0.00319	0.00725	CcSEcCtD
Carvedilol—Pharyngitis—Octreotide—thymus cancer	0.00319	0.00723	CcSEcCtD
Carvedilol—Oedema peripheral—Octreotide—thymus cancer	0.00316	0.00718	CcSEcCtD
Carvedilol—NDUFC2—bone marrow—thymus cancer	0.00314	0.00724	CbGeAlD
Carvedilol—NDUFC2—thyroid gland—thymus cancer	0.00313	0.00722	CbGeAlD
Carvedilol—HIF1A—Signaling by NOTCH—MAML2—thymus cancer	0.00312	0.0249	CbGpPWpGaD
Carvedilol—Visual impairment—Octreotide—thymus cancer	0.00309	0.00702	CcSEcCtD
Carvedilol—VCAM1—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD8A—thymus cancer	0.00308	0.0246	CbGpPWpGaD
Carvedilol—Tinnitus—Octreotide—thymus cancer	0.00299	0.0068	CcSEcCtD
Carvedilol—Immune system disorder—Octreotide—thymus cancer	0.0029	0.00658	CcSEcCtD
Carvedilol—GJA1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—thymus cancer	0.00288	0.0229	CbGpPWpGaD
Carvedilol—VEGFA—bone marrow—thymus cancer	0.00285	0.00657	CbGeAlD
Carvedilol—NDUFC2—lung—thymus cancer	0.00285	0.00656	CbGeAlD
Carvedilol—VEGFA—thyroid gland—thymus cancer	0.00284	0.00655	CbGeAlD
Carvedilol—Alopecia—Octreotide—thymus cancer	0.00284	0.00644	CcSEcCtD
Carvedilol—Malnutrition—Octreotide—thymus cancer	0.00279	0.00635	CcSEcCtD
Carvedilol—Flatulence—Octreotide—thymus cancer	0.00275	0.00625	CcSEcCtD
Carvedilol—Tension—Octreotide—thymus cancer	0.00274	0.00623	CcSEcCtD
Carvedilol—Nervousness—Octreotide—thymus cancer	0.00271	0.00616	CcSEcCtD
Carvedilol—Back pain—Octreotide—thymus cancer	0.0027	0.00614	CcSEcCtD
Carvedilol—Muscle spasms—Octreotide—thymus cancer	0.00269	0.0061	CcSEcCtD
Carvedilol—ADRA1D—epithelium—thymus cancer	0.00266	0.00612	CbGeAlD
Carvedilol—Vision blurred—Octreotide—thymus cancer	0.00263	0.00598	CcSEcCtD
Carvedilol—HIF1A—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—thymus cancer	0.00263	0.021	CbGpPWpGaD
Carvedilol—SELE—lymph node—thymus cancer	0.00261	0.006	CbGeAlD
Carvedilol—Ill-defined disorder—Octreotide—thymus cancer	0.00259	0.00589	CcSEcCtD
Carvedilol—VEGFA—lung—thymus cancer	0.00258	0.00595	CbGeAlD
Carvedilol—Anaemia—Octreotide—thymus cancer	0.00258	0.00586	CcSEcCtD
Carvedilol—Malaise—Octreotide—thymus cancer	0.00252	0.00572	CcSEcCtD
Carvedilol—Vertigo—Octreotide—thymus cancer	0.00251	0.0057	CcSEcCtD
Carvedilol—Syncope—Octreotide—thymus cancer	0.00251	0.00569	CcSEcCtD
Carvedilol—Palpitations—Octreotide—thymus cancer	0.00247	0.00561	CcSEcCtD
Carvedilol—Loss of consciousness—Octreotide—thymus cancer	0.00246	0.00558	CcSEcCtD
Carvedilol—Cough—Octreotide—thymus cancer	0.00244	0.00554	CcSEcCtD
Carvedilol—Convulsion—Octreotide—thymus cancer	0.00242	0.0055	CcSEcCtD
Carvedilol—Hypertension—Octreotide—thymus cancer	0.00241	0.00548	CcSEcCtD
Carvedilol—VCAM1—lymph node—thymus cancer	0.0024	0.00552	CbGeAlD
Carvedilol—Myalgia—Octreotide—thymus cancer	0.00238	0.0054	CcSEcCtD
Carvedilol—Chest pain—Octreotide—thymus cancer	0.00238	0.0054	CcSEcCtD
Carvedilol—Arthralgia—Octreotide—thymus cancer	0.00238	0.0054	CcSEcCtD
Carvedilol—NPPB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.00237	0.0189	CbGpPWpGaD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00236	0.00537	CcSEcCtD
Carvedilol—Discomfort—Octreotide—thymus cancer	0.00235	0.00534	CcSEcCtD
Carvedilol—Dry mouth—Octreotide—thymus cancer	0.00233	0.00528	CcSEcCtD
Carvedilol—HIF1A—lymph node—thymus cancer	0.00231	0.00531	CbGeAlD
Carvedilol—Oedema—Octreotide—thymus cancer	0.00228	0.00518	CcSEcCtD
Carvedilol—Anaphylactic shock—Octreotide—thymus cancer	0.00228	0.00518	CcSEcCtD
Carvedilol—Infection—Octreotide—thymus cancer	0.00227	0.00514	CcSEcCtD
Carvedilol—Shock—Octreotide—thymus cancer	0.00224	0.0051	CcSEcCtD
Carvedilol—GJA1—lymph node—thymus cancer	0.00224	0.00515	CbGeAlD
Carvedilol—Thrombocytopenia—Octreotide—thymus cancer	0.00223	0.00507	CcSEcCtD
Carvedilol—Tachycardia—Octreotide—thymus cancer	0.00223	0.00505	CcSEcCtD
Carvedilol—Skin disorder—Octreotide—thymus cancer	0.00221	0.00503	CcSEcCtD
Carvedilol—Hyperhidrosis—Octreotide—thymus cancer	0.0022	0.00501	CcSEcCtD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.00218	0.0174	CbGpPWpGaD
Carvedilol—Anorexia—Octreotide—thymus cancer	0.00217	0.00494	CcSEcCtD
Carvedilol—HIF1A—Notch-mediated HES/HEY network—CD4—thymus cancer	0.00216	0.0172	CbGpPWpGaD
Carvedilol—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00208	0.00472	CcSEcCtD
Carvedilol—Insomnia—Octreotide—thymus cancer	0.00206	0.00468	CcSEcCtD
Carvedilol—Paraesthesia—Octreotide—thymus cancer	0.00205	0.00465	CcSEcCtD
Carvedilol—Dyspnoea—Octreotide—thymus cancer	0.00203	0.00462	CcSEcCtD
Carvedilol—Somnolence—Octreotide—thymus cancer	0.00203	0.0046	CcSEcCtD
Carvedilol—Dyspepsia—Octreotide—thymus cancer	0.00201	0.00456	CcSEcCtD
Carvedilol—Decreased appetite—Octreotide—thymus cancer	0.00198	0.0045	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Octreotide—thymus cancer	0.00197	0.00447	CcSEcCtD
Carvedilol—Fatigue—Octreotide—thymus cancer	0.00197	0.00446	CcSEcCtD
Carvedilol—KCNH2—Neuronal System—KCNA4—thymus cancer	0.00196	0.0156	CbGpPWpGaD
Carvedilol—Constipation—Octreotide—thymus cancer	0.00195	0.00443	CcSEcCtD
Carvedilol—Pain—Octreotide—thymus cancer	0.00195	0.00443	CcSEcCtD
Carvedilol—NDUFC2—lymph node—thymus cancer	0.00195	0.00448	CbGeAlD
Carvedilol—Feeling abnormal—Octreotide—thymus cancer	0.00188	0.00427	CcSEcCtD
Carvedilol—Gastrointestinal pain—Octreotide—thymus cancer	0.00186	0.00423	CcSEcCtD
Carvedilol—HIF1A—Angiogenesis—AKT1—thymus cancer	0.00184	0.0147	CbGpPWpGaD
Carvedilol—Urticaria—Octreotide—thymus cancer	0.00181	0.00411	CcSEcCtD
Carvedilol—Body temperature increased—Octreotide—thymus cancer	0.0018	0.00409	CcSEcCtD
Carvedilol—Abdominal pain—Octreotide—thymus cancer	0.0018	0.00409	CcSEcCtD
Carvedilol—VEGFA—lymph node—thymus cancer	0.00177	0.00407	CbGeAlD
Carvedilol—GJA1—AP-1 transcription factor network—CDKN2A—thymus cancer	0.00173	0.0138	CbGpPWpGaD
Carvedilol—VEGFA—Axon guidance—DPYSL5—thymus cancer	0.00171	0.0136	CbGpPWpGaD
Carvedilol—Hypersensitivity—Octreotide—thymus cancer	0.00168	0.00382	CcSEcCtD
Carvedilol—ADRA1A—hematopoietic system—thymus cancer	0.00167	0.00384	CbGeAlD
Carvedilol—HIF1A—AP-1 transcription factor network—CDKN2A—thymus cancer	0.00167	0.0133	CbGpPWpGaD
Carvedilol—Asthenia—Octreotide—thymus cancer	0.00164	0.00372	CcSEcCtD
Carvedilol—Pruritus—Octreotide—thymus cancer	0.00161	0.00366	CcSEcCtD
Carvedilol—KCNH2—hematopoietic system—thymus cancer	0.00161	0.00371	CbGeAlD
Carvedilol—SELE—Thromboxane A2 receptor signaling—AKT1—thymus cancer	0.0016	0.0128	CbGpPWpGaD
Carvedilol—ADRB1—cardiac atrium—thymus cancer	0.0016	0.00369	CbGeAlD
Carvedilol—HIF1A—VEGFR1 specific signals—AKT1—thymus cancer	0.00158	0.0126	CbGpPWpGaD
Carvedilol—Diarrhoea—Octreotide—thymus cancer	0.00156	0.00354	CcSEcCtD
Carvedilol—ADRA1A—epithelium—thymus cancer	0.00153	0.00351	CbGeAlD
Carvedilol—Dizziness—Octreotide—thymus cancer	0.00151	0.00342	CcSEcCtD
Carvedilol—GJA1—AP-1 transcription factor network—IL2—thymus cancer	0.0015	0.0119	CbGpPWpGaD
Carvedilol—Vomiting—Octreotide—thymus cancer	0.00145	0.00329	CcSEcCtD
Carvedilol—HIF1A—AP-1 transcription factor network—IL2—thymus cancer	0.00144	0.0115	CbGpPWpGaD
Carvedilol—Rash—Octreotide—thymus cancer	0.00144	0.00327	CcSEcCtD
Carvedilol—Dermatitis—Octreotide—thymus cancer	0.00144	0.00326	CcSEcCtD
Carvedilol—Headache—Octreotide—thymus cancer	0.00143	0.00324	CcSEcCtD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.0014	0.0111	CbGpPWpGaD
Carvedilol—VEGFA—Bladder Cancer—CDKN2A—thymus cancer	0.00138	0.011	CbGpPWpGaD
Carvedilol—CYP1A2—hematopoietic system—thymus cancer	0.00138	0.00318	CbGeAlD
Carvedilol—CYP1A1—hematopoietic system—thymus cancer	0.00136	0.00313	CbGeAlD
Carvedilol—Nausea—Octreotide—thymus cancer	0.00135	0.00308	CcSEcCtD
Carvedilol—CYP2C9—hematopoietic system—thymus cancer	0.00131	0.00302	CbGeAlD
Carvedilol—ADRA2A—hematopoietic system—thymus cancer	0.00127	0.00292	CbGeAlD
Carvedilol—CYP1A1—epithelium—thymus cancer	0.00124	0.00287	CbGeAlD
Carvedilol—CYP2E1—hematopoietic system—thymus cancer	0.00124	0.00286	CbGeAlD
Carvedilol—ADRB1—lung—thymus cancer	0.00123	0.00282	CbGeAlD
Carvedilol—KCNH2—cardiac atrium—thymus cancer	0.00122	0.00282	CbGeAlD
Carvedilol—VEGFA—Developmental Biology—DPYSL5—thymus cancer	0.00122	0.00971	CbGpPWpGaD
Carvedilol—ADRA2C—cardiac atrium—thymus cancer	0.00121	0.00278	CbGeAlD
Carvedilol—GJA1—Corticotropin-releasing hormone—IL2—thymus cancer	0.0012	0.00959	CbGpPWpGaD
Carvedilol—VEGFA—Differentiation Pathway—KIT—thymus cancer	0.0012	0.00954	CbGpPWpGaD
Carvedilol—PTGS1—hematopoietic system—thymus cancer	0.0012	0.00275	CbGeAlD
Carvedilol—KCNH2—pituitary gland—thymus cancer	0.0012	0.00275	CbGeAlD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.00118	0.00941	CbGpPWpGaD
Carvedilol—ADRA2C—pituitary gland—thymus cancer	0.00118	0.00272	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—thymus cancer	0.00117	0.00271	CbGeAlD
Carvedilol—PTGS1—epithelium—thymus cancer	0.00109	0.00252	CbGeAlD
Carvedilol—SELE—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.00108	0.00858	CbGpPWpGaD
Carvedilol—VCAM1—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.00107	0.00854	CbGpPWpGaD
Carvedilol—VCAM1—Thromboxane A2 receptor signaling—AKT1—thymus cancer	0.00106	0.00842	CbGpPWpGaD
Carvedilol—CYP1A1—cardiac atrium—thymus cancer	0.00103	0.00238	CbGeAlD
Carvedilol—KCNH2—bone marrow—thymus cancer	0.00103	0.00238	CbGeAlD
Carvedilol—GJA1—Wnt Signaling Pathway Netpath—AKT1—thymus cancer	0.00103	0.00821	CbGpPWpGaD
Carvedilol—CYP3A4—hematopoietic system—thymus cancer	0.000999	0.0023	CbGeAlD
Carvedilol—GJA1—Spinal Cord Injury—IL2—thymus cancer	0.000986	0.00786	CbGpPWpGaD
Carvedilol—HIF1A—Oncostatin M Signaling Pathway—TP53—thymus cancer	0.000984	0.00784	CbGpPWpGaD
Carvedilol—CYP2D6—hematopoietic system—thymus cancer	0.000983	0.00226	CbGeAlD
Carvedilol—ADRA2A—cardiac atrium—thymus cancer	0.000963	0.00222	CbGeAlD
Carvedilol—GJA1—AP-1 transcription factor network—TP53—thymus cancer	0.000962	0.00766	CbGpPWpGaD
Carvedilol—ADRA2A—pituitary gland—thymus cancer	0.000941	0.00217	CbGeAlD
Carvedilol—HIF1A—AP-1 transcription factor network—TP53—thymus cancer	0.000927	0.00739	CbGpPWpGaD
Carvedilol—ADRA2C—lung—thymus cancer	0.000924	0.00213	CbGeAlD
Carvedilol—PTGS1—cardiac atrium—thymus cancer	0.000908	0.00209	CbGeAlD
Carvedilol—PTGS1—pituitary gland—thymus cancer	0.000887	0.00204	CbGeAlD
Carvedilol—CYP1A2—thyroid gland—thymus cancer	0.000882	0.00203	CbGeAlD
Carvedilol—HIF1A—Notch Signaling Pathway—AKT1—thymus cancer	0.000874	0.00697	CbGpPWpGaD
Carvedilol—CYP2E1—lymphoid tissue—thymus cancer	0.000874	0.00201	CbGeAlD
Carvedilol—CYP1A1—thyroid gland—thymus cancer	0.00087	0.002	CbGeAlD
Carvedilol—HIF1A—Oncostatin M Signaling Pathway—AKT1—thymus cancer	0.000831	0.00662	CbGpPWpGaD
Carvedilol—HIF1A—AGE/RAGE pathway—AKT1—thymus cancer	0.000821	0.00654	CbGpPWpGaD
Carvedilol—HIF1A—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000821	0.00654	CbGpPWpGaD
Carvedilol—ADRA2A—thyroid gland—thymus cancer	0.000811	0.00187	CbGeAlD
Carvedilol—CYP1A2—lung—thymus cancer	0.000801	0.00185	CbGeAlD
Carvedilol—VEGFA—Angiogenesis—AKT1—thymus cancer	0.000796	0.00634	CbGpPWpGaD
Carvedilol—CYP2E1—thyroid gland—thymus cancer	0.000794	0.00183	CbGeAlD
Carvedilol—CYP1A1—lung—thymus cancer	0.000791	0.00182	CbGeAlD
Carvedilol—VEGFA—S1P3 pathway—AKT1—thymus cancer	0.00077	0.00614	CbGpPWpGaD
Carvedilol—VEGFA—Bladder Cancer—TP53—thymus cancer	0.000768	0.00612	CbGpPWpGaD
Carvedilol—PTGS1—thyroid gland—thymus cancer	0.000765	0.00176	CbGeAlD
Carvedilol—ADRA2A—lung—thymus cancer	0.000737	0.0017	CbGeAlD
Carvedilol—VEGFA—SHP2 signaling—IL2—thymus cancer	0.000724	0.00577	CbGpPWpGaD
Carvedilol—CYP2E1—lung—thymus cancer	0.000721	0.00166	CbGeAlD
Carvedilol—ABCB1—hematopoietic system—thymus cancer	0.000707	0.00163	CbGeAlD
Carvedilol—PTGS1—lung—thymus cancer	0.000694	0.0016	CbGeAlD
Carvedilol—VEGFA—VEGFR1 specific signals—AKT1—thymus cancer	0.000684	0.00545	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CYLD—thymus cancer	0.00068	0.00542	CbGpPWpGaD
Carvedilol—GJA1—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000653	0.0052	CbGpPWpGaD
Carvedilol—HIF1A—Signaling by NOTCH—TP53—thymus cancer	0.000651	0.00518	CbGpPWpGaD
Carvedilol—ABCB1—epithelium—thymus cancer	0.000646	0.00149	CbGeAlD
Carvedilol—KCNH2—lymph node—thymus cancer	0.00064	0.00147	CbGeAlD
Carvedilol—GJA1—Spinal Cord Injury—TP53—thymus cancer	0.000633	0.00505	CbGpPWpGaD
Carvedilol—ADRA2C—lymph node—thymus cancer	0.000632	0.00145	CbGeAlD
Carvedilol—HIF1A—Cellular responses to stress—CDKN2A—thymus cancer	0.000576	0.00459	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—IL2—thymus cancer	0.000566	0.00451	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—CD8A—thymus cancer	0.000548	0.00436	CbGpPWpGaD
Carvedilol—CYP1A1—lymph node—thymus cancer	0.000541	0.00125	CbGeAlD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000538	0.00428	CbGpPWpGaD
Carvedilol—ABCB1—pituitary gland—thymus cancer	0.000524	0.00121	CbGeAlD
Carvedilol—SELE—Hemostasis—IL2—thymus cancer	0.000508	0.00405	CbGpPWpGaD
Carvedilol—ADRA2A—lymph node—thymus cancer	0.000504	0.00116	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—thymus cancer	0.000498	0.00115	CbGeAlD
Carvedilol—PTGS1—lymph node—thymus cancer	0.000475	0.00109	CbGeAlD
Carvedilol—ABCB1—bone marrow—thymus cancer	0.000453	0.00104	CbGeAlD
Carvedilol—ABCB1—thyroid gland—thymus cancer	0.000452	0.00104	CbGeAlD
Carvedilol—HIF1A—Disease—MAML2—thymus cancer	0.000442	0.00352	CbGpPWpGaD
Carvedilol—VEGFA—Oncostatin M Signaling Pathway—TP53—thymus cancer	0.000425	0.00338	CbGpPWpGaD
Carvedilol—GJA1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000415	0.00331	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—KIT—thymus cancer	0.000411	0.00328	CbGpPWpGaD
Carvedilol—ABCB1—lung—thymus cancer	0.000411	0.000946	CbGeAlD
Carvedilol—VEGFA—Integrins in angiogenesis—AKT1—thymus cancer	0.000368	0.00293	CbGpPWpGaD
Carvedilol—GJA1—Membrane Trafficking—AKT1—thymus cancer	0.000365	0.00291	CbGpPWpGaD
Carvedilol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.000364	0.0029	CbGpPWpGaD
Carvedilol—VEGFA—Endochondral Ossification—AKT1—thymus cancer	0.000363	0.00289	CbGpPWpGaD
Carvedilol—VEGFA—Oncostatin M Signaling Pathway—AKT1—thymus cancer	0.000359	0.00286	CbGpPWpGaD
Carvedilol—VEGFA—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000354	0.00282	CbGpPWpGaD
Carvedilol—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	0.000346	0.00276	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000338	0.00269	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD8A—thymus cancer	0.000332	0.00265	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet Aggregation (Plug Formation)—AKT1—thymus cancer	0.000332	0.00264	CbGpPWpGaD
Carvedilol—SELE—Hemostasis—TP53—thymus cancer	0.000326	0.0026	CbGpPWpGaD
Carvedilol—HIF1A—Cellular responses to stress—TP53—thymus cancer	0.000321	0.00255	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—CD4—thymus cancer	0.000315	0.00251	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet Aggregation (Plug Formation)—AKT1—thymus cancer	0.00031	0.00247	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MAML2—thymus cancer	0.00031	0.00247	CbGpPWpGaD
Carvedilol—ABCB1—lymph node—thymus cancer	0.000281	0.000647	CbGeAlD
Carvedilol—SELE—Hemostasis—AKT1—thymus cancer	0.000275	0.00219	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—thymus cancer	0.000252	0.00201	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—KIT—thymus cancer	0.00025	0.00199	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—CDKN2A—thymus cancer	0.000249	0.00198	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000248	0.00198	CbGpPWpGaD
Carvedilol—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	0.000241	0.00192	CbGpPWpGaD
Carvedilol—VEGFA—Signaling by VEGF—AKT1—thymus cancer	0.000227	0.00181	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—TP53—thymus cancer	0.000219	0.00175	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000216	0.00172	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000215	0.00172	CbGpPWpGaD
Carvedilol—HIF1A—Disease—KIT—thymus cancer	0.000204	0.00163	CbGpPWpGaD
Carvedilol—ADRA1B—LPA receptor mediated events—AKT1—thymus cancer	0.000197	0.00157	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—TP53—thymus cancer	0.000195	0.00155	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD4—thymus cancer	0.000191	0.00152	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—AKT1—thymus cancer	0.000185	0.00148	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000183	0.00146	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000179	0.00143	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IL2—thymus cancer	0.000176	0.0014	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000175	0.00139	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—AKT1—thymus cancer	0.000165	0.00131	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—AKT1—thymus cancer	0.000157	0.00125	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CD4—thymus cancer	0.000156	0.00124	CbGpPWpGaD
Carvedilol—VEGFA—Focal Adhesion—AKT1—thymus cancer	0.000152	0.00121	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000151	0.00121	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000146	0.00117	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—KIT—thymus cancer	0.000143	0.00114	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—TP53—thymus cancer	0.000138	0.0011	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000137	0.00109	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000135	0.00107	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MAML2—thymus cancer	0.000134	0.00107	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MAML2—thymus cancer	0.000134	0.00106	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—IL2—thymus cancer	0.000128	0.00102	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000111	0.000885	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.00011	0.000873	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL2—thymus cancer	0.000101	0.000802	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—AKT1—thymus cancer	9.52e-05	0.000759	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAML2—thymus cancer	8.72e-05	0.000695	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—AKT1—thymus cancer	8.46e-05	0.000674	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TP53—thymus cancer	8.22e-05	0.000655	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—IL2—thymus cancer	8.11e-05	0.000646	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAML2—thymus cancer	7.95e-05	0.000633	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thymus cancer	7.94e-05	0.000633	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAML2—thymus cancer	7.88e-05	0.000628	CbGpPWpGaD
Carvedilol—HIF1A—Disease—AKT1—thymus cancer	7.79e-05	0.000621	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAML2—thymus cancer	7.78e-05	0.00062	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—IL2—thymus cancer	7.55e-05	0.000601	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—AKT1—thymus cancer	7.42e-05	0.000591	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL2—thymus cancer	7.37e-05	0.000587	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAML2—thymus cancer	7.36e-05	0.000586	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAML2—thymus cancer	7.24e-05	0.000577	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—AKT1—thymus cancer	7.08e-05	0.000564	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—IL2—thymus cancer	7.05e-05	0.000562	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—AKT1—thymus cancer	6.94e-05	0.000553	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TP53—thymus cancer	6.46e-05	0.000515	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAML2—thymus cancer	6.43e-05	0.000512	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—KIT—thymus cancer	6.18e-05	0.000493	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—KIT—thymus cancer	6.17e-05	0.000492	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thymus cancer	6.02e-05	0.00048	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAML2—thymus cancer	5.98e-05	0.000476	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—IL2—thymus cancer	5.73e-05	0.000456	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	5.54e-05	0.000442	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—AKT1—thymus cancer	5.46e-05	0.000435	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—IL2—thymus cancer	5.28e-05	0.000421	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—thymus cancer	4.85e-05	0.000386	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—thymus cancer	4.81e-05	0.000384	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—thymus cancer	4.8e-05	0.000382	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—thymus cancer	4.77e-05	0.00038	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—thymus cancer	4.71e-05	0.000375	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	4.68e-05	0.000373	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—thymus cancer	4.53e-05	0.000361	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—thymus cancer	4.46e-05	0.000355	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—AKT1—thymus cancer	4.4e-05	0.00035	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—thymus cancer	4.39e-05	0.000349	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—thymus cancer	4.37e-05	0.000348	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—thymus cancer	4.35e-05	0.000347	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—thymus cancer	4.34e-05	0.000346	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—thymus cancer	4.33e-05	0.000345	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—thymus cancer	4.28e-05	0.000341	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—AKT1—thymus cancer	4.09e-05	0.000326	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—thymus cancer	4.05e-05	0.000322	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—KIT—thymus cancer	4.03e-05	0.000321	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—AKT1—thymus cancer	3.99e-05	0.000318	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—thymus cancer	3.98e-05	0.000317	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—thymus cancer	3.9e-05	0.00031	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—AKT1—thymus cancer	3.82e-05	0.000305	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—thymus cancer	3.68e-05	0.000293	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—KIT—thymus cancer	3.67e-05	0.000292	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—KIT—thymus cancer	3.64e-05	0.00029	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—thymus cancer	3.62e-05	0.000288	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—KIT—thymus cancer	3.59e-05	0.000286	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—thymus cancer	3.54e-05	0.000282	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KIT—thymus cancer	3.4e-05	0.000271	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KIT—thymus cancer	3.34e-05	0.000266	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—thymus cancer	3.3e-05	0.000263	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—thymus cancer	3.29e-05	0.000262	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—thymus cancer	3.11e-05	0.000247	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KIT—thymus cancer	2.97e-05	0.000237	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—thymus cancer	2.87e-05	0.000228	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—thymus cancer	2.83e-05	0.000226	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—thymus cancer	2.79e-05	0.000223	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—thymus cancer	2.79e-05	0.000222	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KIT—thymus cancer	2.76e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—thymus cancer	2.61e-05	0.000208	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—thymus cancer	2.6e-05	0.000207	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—thymus cancer	2.59e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—thymus cancer	2.58e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—thymus cancer	2.56e-05	0.000204	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—thymus cancer	2.55e-05	0.000203	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—thymus cancer	2.53e-05	0.000201	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—thymus cancer	2.42e-05	0.000192	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—thymus cancer	2.39e-05	0.00019	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—thymus cancer	2.38e-05	0.000189	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—thymus cancer	2.37e-05	0.000189	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—thymus cancer	2.36e-05	0.000188	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—thymus cancer	2.35e-05	0.000188	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—thymus cancer	2.35e-05	0.000187	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—thymus cancer	2.35e-05	0.000187	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—thymus cancer	2.32e-05	0.000185	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—thymus cancer	2.19e-05	0.000175	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—thymus cancer	2.16e-05	0.000172	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—thymus cancer	2.11e-05	0.000168	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—thymus cancer	2.09e-05	0.000166	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—thymus cancer	1.96e-05	0.000156	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—thymus cancer	1.94e-05	0.000155	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—thymus cancer	1.92e-05	0.000153	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—thymus cancer	1.82e-05	0.000145	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—thymus cancer	1.78e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—thymus cancer	1.66e-05	0.000132	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—thymus cancer	1.64e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—thymus cancer	1.62e-05	0.000129	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—thymus cancer	1.55e-05	0.000123	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—thymus cancer	1.55e-05	0.000123	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—thymus cancer	1.54e-05	0.000122	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—thymus cancer	1.53e-05	0.000122	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—thymus cancer	1.51e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—thymus cancer	1.4e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—thymus cancer	1.39e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—thymus cancer	1.37e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—thymus cancer	1.34e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—thymus cancer	1.3e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—thymus cancer	1.28e-05	0.000102	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—thymus cancer	1.26e-05	0.0001	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—thymus cancer	1.25e-05	9.93e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—thymus cancer	1.16e-05	9.21e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—thymus cancer	1.13e-05	9.03e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—thymus cancer	1.09e-05	8.68e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—thymus cancer	1.05e-05	8.39e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—thymus cancer	8.71e-06	6.94e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—thymus cancer	8.2e-06	6.54e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—thymus cancer	8.13e-06	6.48e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—thymus cancer	6.95e-06	5.54e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—thymus cancer	5.36e-06	4.27e-05	CbGpPWpGaD
